VitaNova Life Sciences reported a gross margin of 14.83% and a net margin of 0.98% for the quarter ended Apr 2026. These financial ratios cover 35 quarters of results from Apr 2017 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Apr2017 | Jul2017 | Oct2017 | Jan2018 | Apr2018 | Jul2018 | Oct2018 | Jan2019 | Oct2019 | Jan2020 | Apr2020 | Jul2020 | Oct2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||
| Gross Margin | 100.00% | 64.56% | 67.45% | 53.35% | 61.40% | 59.26% | 66.20% | 61.06% | 44.58% | 14.83% | |||||||||||||||||||||||||
| EBT Margin | 33.35% | 29.72% | -59.57% | 14.23% | 26.01% | -245.77% | -146.17% | 22.79% | 42.75% | -41.87% | 20.80% | 35.11% | 55.33% | -31.22% | 23.25% | 6.59% | -5.99% | ||||||||||||||||||
| EBIT Margin | -66.65% | 29.72% | -59.57% | 14.23% | 26.01% | -245.77% | -146.17% | 22.79% | 42.73% | -41.87% | 21.43% | 35.31% | 55.41% | -31.22% | 23.22% | 6.59% | -6.15% | ||||||||||||||||||
| EBITDA Margin | -66.65% | 29.72% | -59.57% | 14.23% | 26.01% | -245.77% | -146.17% | 22.79% | 42.73% | -41.87% | 21.43% | 35.31% | 55.41% | -31.22% | 23.22% | 6.59% | -6.15% | ||||||||||||||||||
| Operating Margin | -66.65% | 14.23% | 22.79% | 42.73% | -41.87% | 21.43% | 35.31% | 55.41% | -31.22% | 23.22% | 6.59% | -6.15% | |||||||||||||||||||||||
| Net Margin | 33.35% | 29.72% | -59.57% | 14.23% | 26.01% | -245.77% | -146.17% | 22.79% | 30.83% | -50.90% | 11.18% | 23.67% | 40.98% | -44.56% | 8.38% | -6.25% | 0.98% | ||||||||||||||||||
| FCF Margin | 43.54% | 17.47% | -30.74% | 45.21% | 53.06% | -281.77% | -76.17% | -576.85% | -35.11% | -464.62% | 3.00% | 67.75% | 24.53% | 253.91% | 49.79% | -12.74% | 24.00% | ||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.17M | 0.26M | 0.24M | 0.12M | 0.03M | 0.01M | 0.07M | 0.12M | |||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 0.04M | 0.03M | 0.03M | 0.03M | 0.02M | 0.01M | 1.08M | 1.20M | 1.23M | 1.29M | 1.79M | 2.25M | 2.29M | 2.32M | 2.38M | ||||||||||||||||||||
| Invested CapitalInvested Cap. | -0.03M | -0.00M | 0.00M | -0.02M | -0.02M | -0.02M | -0.04M | ||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 2.03 | 3.67 | 5.10 | 3.07 | 3.46 | 3.85 | 0.53 | 0.57 | 0.79 | 0.97 | 1.49 | 1.18 | 1.22 | 1.37 | 1.27 | ||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | 29.46 | 133.92 | 690.21 | ||||||||||||||||||||||||||||||||
| Debt Ratio | 0.38 | 0.29 | 0.52 | 0.40 | 0.34 | 1.46 | |||||||||||||||||||||||||||||
| Times Interest Earned | 29.46 | 133.92 | 690.21 | ||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -335.10 | 0.01M | 0.01M | -860.01 | -0.01M | -0.00M | -0.00M | 0.00M | 114.09 | -244.64 | 413.72 | 185.08 | 16.88 | -291.71 | 0.00M | -907.76 | 655.63 | ||||||||||||||||||
| Price to SalesP/S | 199.62 | 0.00M | 0.00M | 0.00M | 0.02M | 419.26 | 35.18 | 124.51 | 46.24 | 43.81 | 6.92 | 130.00 | 282.85 | 56.75 | 6.45 | ||||||||||||||||||||
| Price to BookP/B | -256.75 | -670.15 | -0.00M | -385.49 | -892.36 | -626.79 | -114.60 | 12.57 | 18.14 | 13.49 | 13.05 | 12.19 | 7.08 | 7.25 | 63.64 | 21.72 | 5.61 | ||||||||||||||||||
| Enterprise Value | 8.96M | 21.99M | 35.19M | 21.13M | 52.83M | 52.31M | 10.57M | 10.13M | 18.57M | 13.36M | 13.28M | 13.10M | 12.72M | 12.46M | 119.55M | 39.10M | 9.91M | ||||||||||||||||||
| EV to EBIT | -334.24 | 0.01M | 0.01M | -859.56 | -0.01M | -0.00M | -0.00M | 0.00M | 79.79 | -294.29 | 212.20 | 120.34 | 11.76 | -384.09 | 0.00M | 836.73 | -90.19 | ||||||||||||||||||
| EV to EBITDA | -334.24 | 0.01M | 0.01M | -859.56 | -0.01M | -0.00M | -0.00M | 0.00M | 79.79 | -294.29 | 212.20 | 120.34 | 11.76 | -384.09 | 0.00M | 836.73 | -90.19 | ||||||||||||||||||
| Market Capitalization | 8.98M | 22.02M | 35.23M | 21.14M | 52.84M | 52.31M | 10.57M | 10.94M | 19.16M | 13.51M | 13.51M | 13.51M | 13.51M | 13.51M | 120.81M | 40.27M | 11.51M | ||||||||||||||||||
| Price to FCFP/FCF | -649.44 | 0.00M | 0.01M | -750.13 | -0.02M | -0.00M | -0.00M | -72.68 | -100.21 | -26.80 | 0.00M | 64.66 | 28.19 | 51.20 | 568.08 | -445.58 | 26.86 | ||||||||||||||||||
| EV to FCF | -647.77 | 0.00M | 0.01M | -749.74 | -0.02M | -0.00M | -0.00M | -67.31 | -97.11 | -26.52 | 0.00M | 62.72 | 26.56 | 47.23 | 562.16 | -432.64 | 23.13 | ||||||||||||||||||
| EV to CFO | -647.77 | 0.00M | 0.01M | -749.74 | -0.02M | -0.00M | -0.00M | -67.31 | -97.11 | -26.52 | 0.00M | 62.72 | 26.56 | 47.23 | 562.16 | -432.64 | 23.13 | ||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -66.65% | 29.72% | -59.57% | 14.23% | 26.01% | -245.77% | -146.17% | -220.03% | -476.65% | 22.79% | 42.73% | -41.87% | 21.43% | 35.31% | 55.41% | -31.22% | 23.22% | 6.59% | -6.15% | ||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 423.46% | 229.93% | 126.22% | 39.98% | 109.14% | 41.72% | 21.84% | 18.49% | 25.43% | 33.30% | 83.84% | 65.33% | 67.95% | 64.08% | 0.18% | ||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 178.15% | 387.04% | 10,991.52% | ||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | 395.38% | 427.08% | -2.82% | -40.43% | -201.93% | -245.45% | 13.06% | 9.18% | 12.30% | 16.93% | 47.56% | 38.22% | 37.69% | 32.08% | -1.57% |